Mary M Stevenson

Title: Mary M. Stevenson: Immunogenicity and Infection Research

Introduction

Mary M. Stevenson is an inventor associated with Montreal, Canada, and research institutions including McGill University and the Queensland Institute of Medical Research. Her work includes an invention focused on immune-based approaches to reducing infection and improving recovery.

Latest Patents

Stevenson is associated with 1 patent: “Immunogenic Agent and Pharmaceutical Composition for Use Against Homologous and Heterologous Pathogens Including Plasmodium spp.” The invention describes an immunogenic agent combining a low dose of antigen from one or more pathogens with an agent that increases interleukin-12 (IL-12) in an animal. Its proposed components include CpG nucleic acid, IL-12 protein, or IL-12 nucleic acid. The patent also describes pharmaceutical and immunotherapeutic compositions, including a vaccine intended to protect against or treat malaria caused by Plasmodium species.

Career Highlights

Stevenson’s listed institutional affiliations include McGill University and the Queensland Institute of Medical Research. The patent reflects research into immunotherapeutic strategies for infections caused by intracellular pathogens.

Collaborations

Michael Good is identified as a coworker associated with Stevenson’s work. The patent’s subject matter also reflects research involving immune responses to pathogens and potential vaccine applications.

Conclusion

Mary M. Stevenson’s patent describes an IL-12-focused immunogenic approach with potential applications in preventing or treating infections, including malaria.